SEC Form 4 · accession 0000904314-18-000001

ALLIED HEALTHCARE PRODUCTS INC · AHPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Aug 20, 2018

Accepted (ET)

Aug 21, 2018 · 2:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000874710

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 20, 2018	J	36,937	$0.00	A	90,514	D
Common Stock^F4,F8	Aug 20, 2018	J	357,304	$0.00	D	137,735	I	Limited Partnership
Common Stock	holding	—	—		—	2,500	I	IRA
Common Stock^F2	holding	—	—		—	94,427	I	Spouse
Common Stock^F3	holding	—	—		—	59,101	I	Trust
Common Stock^F5	holding	—	—		—	7,927	I	Corporation
Common Stock^F6	holding	—	—		—	119,792	I	Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option (right to buy)^F7	$4.05	holding	—	—	—	Nov 13, 2009	Nov 13, 2018	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$5.04	holding	—	—	—	Nov 13, 2010	Nov 13, 2019	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$4.34	holding	—	—	—	Nov 11, 2011	Nov 11, 2020	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$3.555	holding	—	—	—	Nov 10, 2012	Nov 10, 2021	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$2.59	holding	—	—	—	Nov 8, 2013	Nov 8, 2022	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$2.31	holding	—	—	—	Nov 14, 2014	Nov 14, 2023	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$1.58	holding	—	—	—	Nov 13, 2015	Nov 13, 2024	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$1.17	holding	—	—	—	Nov 12, 2016	Nov 12, 2025	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$1.13	holding	—	—	—	Nov 10, 2017	Nov 10, 2026	Common Stock	1,500	1,500	D
Option (right to buy)^F7	$2.22	holding	—	—	—	Nov 9, 2018	Nov 9, 2027	Common Stock	750	750	D

F1Shares acquired in a transfer for no consideration from a family limited partnership, as reported on this Form 4 in the last line item of this Table 1, which transaction is exempt from Section 16 pursuant to Rule 16a-13.
F2The reporting person disclaims any economic benefit in such shares.
F3Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
F4Shares disposed of in a transfer for no consideration from a family limited partnership to the reporting person and members of the reporting person's family, in a transaction exempt from Section 16 pursuant to Rule 16a-13, including the transfer of 36,963.50 shares to the reporting person's direct ownership as reported on this Form 4 in the first line item of the Table 1.
F5Owned by a corporation controlled by the reporting person.
F6Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares.
F7Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full.
F8Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B)